Axelopran for Advanced Cancer in Patients Receiving Opioids

Axelopran for Advanced Cancer in Patients Receiving Opioids

Conditions: Breast Cancer; Lung Cancer; Pancreas Cancer; Prostate Cancer
Interventions: Drug: axelopran
Sponsors: HealthPartners Institute; Glycyx MOR Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

May 6, 2026Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments